Zemplar — Class III drug recall D-0833-2016
Terminated recall by AbbVie Inc., reported 2016-04-27, distributed nationwide. Failed Content Uniformity Specifications
| Recall number | D-0833-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AbbVie Inc., North Chicago, IL, United States |
| Recall initiated | 2016-03-24 |
| Classified | 2016-04-21 |
| Reported by FDA | 2016-04-27 |
| Terminated | 2016-10-20 |
| Distributed | Nationwide (US) |
| Quantity | 307 bottles |
| NDC | 00074-4314, 00074-4314-30, 00074-4317, 00074-4317-30, 00074-4317-73, 00074-9036, 00074-9036-30, 00074-9037, 00074-9037-30 |
| Lot numbers | 1/21, 1055586, 2018 |
Product
Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.
Reason for recall
Failed Content Uniformity Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0833-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.